- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02650310
New Device to Maintain the Embryo Temperature During Transfer (EmbryoTemp)
A New System for Preventing Thermal Stress During Embryo Transfer
The embryo transfer implies transportation from the incubator where they have been at 37 ° C, to the transfer catheter inside a laminar flow hood whose working surface is also maintained at 37 ° C. . From the laboratory to the operating room the embryo is exposed to a temperature drop, and consequently thermal stress occurs, which may compromise its future viability.
The aim of this study is to assess the possible improvement in the clinical results when the embryos are transported in a stable device to avoid the drop in temperature throughout the transfer process.
With the use of this thermosetting device heated to 37 ° C, researchers expect a 15% increase in pregnancy rates.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alicante, Spain, 03016
- Recruiting
- Instituto Bernabeu
-
Contact:
- Rafael Bernabeu, M.D., Ph.D.
- Phone Number: +34965154000
- Email: rbernabeu@institutobernabeu.com
-
Contact:
- Rafael Bernabeu, M.D., Ph.D
- Phone Number: +34965154000
- Email: rbernabeu@institutobernabeu.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cryo-transfer cycles: transfer of embryos vitrified in previous cycles receiving donated eggs inseminated with either conjugal or donated sperm from Instituto Bernabeu bank.
Exclusion Criteria:
- Fresh cycles: transfer of fresh embryos (coming from donated or own eggs), and cryo-transfer cycles from vitrified embryos coming from own oocytes.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Conventional transfer
This arm is the control group (conventional embryo transfer protocol) where there is no intervention.
|
|
|
Experimental: Thermostable device transfer
This arm is the study group: embryo transfer protocol using a new thermostable device.
|
Investigators place the catheter with the loaded embryos into a plastic device at 37ºC in order to maintain the temperature
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ongoing Pregnancy rate
Time Frame: Ongoing pregnancy until 28th week of gestation
|
Achieving an ongoing pregnancy after embryo transfer
|
Ongoing pregnancy until 28th week of gestation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Miscarriage rate
Time Frame: Loss of pregnancy up to 12 weeks of gestation
|
To know the embryonic loss rate after implantation
|
Loss of pregnancy up to 12 weeks of gestation
|
|
Implantation rate
Time Frame: Embryo implantation after 6-7 weeks of gestation
|
To know the embryo implantation rate after the embryo transfer
|
Embryo implantation after 6-7 weeks of gestation
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Instituto Bernabeu Group
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Embryo Transfer
-
GlaxoSmithKlineCompletedEmbryo TransferUnited States
-
Istituto Clinico HumanitasCompletedEmbryo Transfer
-
Premium FertilityRecruiting
-
GlaxoSmithKlineCompleted
-
keqin liuCompletedEmbryo TransferChina
-
Universitaire Ziekenhuizen KU LeuvenJessa Hospital; Imelda Hospital, Bonheiden; GZA Ziekenhuizen Campus Sint-AugustinusCompleted
-
GlaxoSmithKlineCompleted
-
Gynuity Health ProjectsCompleted
-
Instituto Valenciano de Infertilidade de LisboaGedeon Richter Ltd.RecruitingFrozen Embryo TransferPortugal
-
Al Baraka Fertility HospitalCompletedFrozen Embryo TransferBahrain
Clinical Trials on Thermostable device
-
ResMedKlinEra Global ServicesNot yet recruitingObstructive Sleep ApneaAustralia
-
Facet TechnologiesLifeScanCompletedDiabetesUnited States
-
Karolinska InstitutetUnknownDegenerative Disc Disease | Discogenic Low Back PainSweden
-
Cala Health, Inc.Not yet recruiting
-
AOTI Ltd.CompletedDiabetic Foot UlcerUnited Kingdom, United States, Germany, France, Luxembourg
-
International Agency for Research on CancerUniversity of North Carolina Global Project Zambia; Liger Medical LlcCompleted
-
Universitair Ziekenhuis BrusselTerminated
-
University of BernDCB Research AG; Insel Gruppe AG, University Hospital BernCompletedGlucose Metabolism Disorders | Diabetes Mellitus | Endocrine System Diseases | Metabolic DiseaseSwitzerland
-
Neurive Co.,Ltd.CompletedTinnitus | Subjective TinnitusSouth Korea
-
Kasey PhiferThe National Centre for ElectroMagnetic Therapies CICCompletedUnspecified Trauma- and Stressor-Related DisorderUnited Kingdom